Can-Fite BioPharma Ltd.
AMEX: CANF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Pnina Fishman
- Employees
- 5
- Headquarters
- Petah Tikva, Israel
- IPO year
- 2012
- Market cap
- $1.6M
- Website
- https://www.canfite.com
Loading CANF…
Loading profile data…Frequently asked questions about CANF
What does Can-Fite BioPharma Ltd. (CANF) do?
Can-Fite BioPharma Ltd., an Israeli clinical-stage biopharmaceutical company, specializes in the creation of small molecule therapeutic products. These treatments target a range of conditions including various cancers, inflammatory liver disorders, and erectile dysfunction. Its primary drug candidate, Piclidenoson, has successfully advanced thro...
Where does CANF trade?
Can-Fite BioPharma Ltd. (CANF) trades on the New York Stock Exchange American.
What sector is CANF in?
Can-Fite BioPharma Ltd. (CANF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Can-Fite BioPharma Ltd.?
Pnina Fishman is the chief executive officer of Can-Fite BioPharma Ltd. (CANF).
Where is Can-Fite BioPharma Ltd. headquartered?
Can-Fite BioPharma Ltd. is headquartered in Israel.
Does CANF pay a dividend?
Can-Fite BioPharma Ltd. (CANF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CANF go public?
Can-Fite BioPharma Ltd. (CANF) completed its initial public offering in 2012.
Is CANF an ADR?
Yes — CANF is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Can-Fite BioPharma Ltd. reporting and dividends follow the underlying issuer.